Pharmaceutical firms in Pakistan recently introduced advanced GLP-1- and GIP-based medications for people living with chronic diabetes amid the health crisis escalating to an alarming level with one in three adults reported living with high blood sugar, making Pakistan the third most affected country in the world. In addition to imports, some pharmaceutical firms started manufacturing and suppl